Thrombosis pp 197-212 | Cite as

Vessel Injury, Thrombosis, and Platelet Survival

  • Laurence A. Harker
  • Russell Ross
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 102)


Vascular injury triggers platelet reactions of adhesion, aggregation, and release, and these reactions play important roles in hemostasis, thrombosis and thromboembolism, and atherogenesis. Measurement of platelet and fibrinogen turnover rates are indicators of the relative involvement of platelets and fibrin in the thrombotic process, and also provide an objective means of assessing antithrombotic therapy. Isotopic methods are preferred over chemical methods to measure platelet survival time; 51Cr is used most widely to label platelets. Problems of analysis and interpretation of platelet disappearance curves are reviewed briefly.


Platelet Function Newcastle Disease Virus Thrombotic Thrombocytopenic Purpura Platelet Destruction Disappearance Curve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baumgartner HR: The subendothelial surface and thrombosis. In THROMBOSIS; PATHOGENESIS AND CLINICAL TRIALS, edited by Deutsch E, Brinkhous KM, Lechner K, Hinnom S. Stuttgart-New York, FK Schattauer Verlag, 1974, p. 91.Google Scholar
  2. 2.
    Mustard JF, Kinlough-Rathbone RL, Packham MA: Recent status of research in the pathogenesis of thrombosis. THROMB DIATH HAEMORRH (Suppl) 59: 157–188, 1974.Google Scholar
  3. 3.
    Weiss HJ: Platelet physiology and abnormalities of platelet function. N ENGL J MED 293: 531–541, 1975.PubMedCrossRefGoogle Scholar
  4. 4.
    Harker LA, Ross R, Slichter SJ, Scott CR: Homocystine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. J CLIN INVEST 58: 731–741, 1976.PubMedCrossRefGoogle Scholar
  5. 5.
    Ross R, Harker LA: Hyperlipidemia and atherosclerosis: Chronic hyperlipidemia induces lesion initiation and progression by endothelial cell desquamation and lipid accumulation. SCIENCE 193: 1094–1100, 1976.PubMedCrossRefGoogle Scholar
  6. 6.
    Baumgartner HR: Platelet and fibrin deposition of subendothelium: Opposite dependence on blood shear rate. THROMB HAEMOSTAS 38: 133, 1977.Google Scholar
  7. 7.
    Goldsmith HL: The flow of model particles and blood cells and its relation to thrombogenesis. In PROGRESS IN HEMOSTASIS AND THROMBOSIS, edited by Spaet TH, New York, Grune and Stratton, Inc., 1972, p. 97.Google Scholar
  8. 8.
    Jorgenson L: The role of platelet embolism from crumbling thrombi and of platelet aggregates arising in flowing blood. In THROMBOSIS, edited by Sherry S, Brinkhous KM, Genton E. Washington, National Academy of Sciences, 1969, p. 506.Google Scholar
  9. 9.
    Honour AJ, Russel RW: Experimental platelet embolism. BR J EXP PATROL 43: 350–362, 1962.Google Scholar
  10. 10.
    Gunning AJ, Pickering GW, Robb-Smith ART, Russell RR: Mural thrombosis of the internal carotid artery and subsequent embolism. Q J MED 33: 155–195, 1964.PubMedGoogle Scholar
  11. 11.
    Haerem JW: Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. ATHEROSCLEROSIS 19: 529–541, 1974.PubMedCrossRefGoogle Scholar
  12. 12.
    Adelson E, Rheingold JJ, Parker O, Beunaventure A, Crosby WH: Platelet and fibrinogen survival in normal and abnormal states of coagulation. BLOOD 17: 267–281, 1961.PubMedGoogle Scholar
  13. 13.
    Harker LA, Slichter SJ: Platelet and fibrinogen consumption in man. N ENGL J MED 287: 999–1005, 1972.PubMedCrossRefGoogle Scholar
  14. 14.
    Harker LA, Slichter SJ: Arterial and venous thromboembolism: Kinetic characterization and evaluation of therapy. THROMB DIATH HAEMORRH 31: 188–203, 1974.PubMedGoogle Scholar
  15. 15.
    Stuart MJ, Murphy S, Oski FA: A simple nonradioisotope technique for the determination of platelet life-span. N ENGL J MED 292: 1310–1313, 1975.PubMedCrossRefGoogle Scholar
  16. 16.
    Leeksman CHW, Cohen JA: Determination of the lifespan of human blood platelets using diisopropylfluorophosphonate. J CLIN INVEST 35: 964–969, 1956.CrossRefGoogle Scholar
  17. 17.
    Odell TT, Jr., Anderson B: Production of lifespan of platelets. In THE KINETICS OF CELLULAR PROLIFERATION, edited by Stohlman F, Jr. New York, Grune and Stratton, Inc., 1959, p. 278.Google Scholar
  18. 18.
    Najean Y, Ardaillou N: The use of 75Se-methionin for the in vivo study of platelet kinetics. SCAND J HAEMATOL 6: 395–401, 1969.PubMedCrossRefGoogle Scholar
  19. 19.
    Grossman CM, Kohn R, Koch R: Possible errors in the use of P32 orthophosphate for the estimation of platelet life-span. BLOOD 22: 9–18, 1963.PubMedGoogle Scholar
  20. 20.
    Mustard JF, Rowsell HC, Murphy EA: Platelet economy (platelet survival and turnover). BR J HAEMATOL 12: 1–24, 1966.PubMedCrossRefGoogle Scholar
  21. 21.
    Bithall TC, Athens JW, Cartwright GE, Wintrobe MM: Radioactive diisopropylfluorophosphate as a platelet label: An evaluation of in vitro and in vivo techniques. BLOOD 29: 354–372, 1967.Google Scholar
  22. 22.
    Cooney DP, Smith BA, Fawley DE: The use of 32diisopropylfluorophosphate (32DFP) as a platelet label: Evidence for reutilization of this isotope in man. BLOOD 31: 791–805, 1968.PubMedGoogle Scholar
  23. 23.
    Heysel RM: Determination of human platelet survival utilizing C14-labeled serotonin. J CLIN INVEST 40: 2134–2141, 1961.CrossRefGoogle Scholar
  24. 24.
    Aas K, Gardner F: Survival of blood platelets labeled with chromium. J CLIN INVEST 37: 1257–1268, 1958.PubMedCrossRefGoogle Scholar
  25. 25.
    Aster RH, Jandl JH: Platelet sequestration in man. I. Methods. J CLIN INVEST 43: 843–869, 1964.CrossRefGoogle Scholar
  26. 26.
    Murphy S, Gardner FH: Platelet preservation. Effect of storage temperature on maintenance of platelets viability. Deleterious effect of refrigerated storage. N ENGL J MED 280: 1094–1098, 1969.PubMedCrossRefGoogle Scholar
  27. 27.
    Slichter SJ, Harker LA: Preparation and storage of platelet concentrates. I. Preparation: Factors influencing the harvest of viable platelets from whole blood. BR J HAEMATOL 34: 395–402, 1976.PubMedCrossRefGoogle Scholar
  28. 28.
    Slichter SJ, Harker LA: Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. BR J HAEMATOL 34: 403–419, 1976.PubMedCrossRefGoogle Scholar
  29. 29.
    Abrahamsen AF: Platelet survival studies in man–with special reference to thrombosis and atherosclerosis. SCAND J HAEMATOL (Suppl) 3: 7–53, 1968.Google Scholar
  30. 30.
    Thakur ML, Welch MJ, Joist JH, Coleman RE: Indium-111 labeled platelets. Studies on preparation and evaluation of in vitro and in vivo function. THROMB RES 9: 345–357, 1976.PubMedCrossRefGoogle Scholar
  31. 31.
    Scheffel R, McIntyre PA, Evatt B, Dvornicky JA, Jr., Natarajan TK, Bolling DR, Murphy EA: Evaluation of indium-111 as a new high photon yield gamma-emitting “physiological” platelet label. JOHNS HOPKINS MED J 140: 285–293, 1977.PubMedGoogle Scholar
  32. 32.
    Harker LA, Finch CA: Thrombokinetics in man. J CLIN INVEST 963–974, 1969.Google Scholar
  33. 33.
    Ginsburg AD, Aster RH: Kinetic studies with 51Cr-labeled platelet cohorts in rats. J LAB CLIN MED 74: 138a - 144, 1969.Google Scholar
  34. 34.
    Paulus JM: PLATELET KINETICS. Amsterdam, North-Holland Pub. Co., 1971, p. 360.Google Scholar
  35. 35.
    O’Neil B, Firkin B: Platelet survival studies in coagulation disorders, thrombocythemia and conditions associated with atherosclerosis. J LAB CLIN MED 64: 188–201, 1964.Google Scholar
  36. 36.
    Murphy EA, Francis ME: The estimation of blood platelet survival. I. General principles of the study of cell survival. THROMB DIATH HAEMORRH 22: 281–295, 1969.PubMedGoogle Scholar
  37. 37.
    Murphy EA, Francis ME: The estimation of blood platelet survival. II. The multiple hit model. THROMB DIATH HAEMORRH 25: 53–80, 1971.PubMedGoogle Scholar
  38. 38.
    Dornhorst AC: The interpretation of red cell survival curves. BLOOD 6: 1284–1292, 1951.PubMedGoogle Scholar
  39. 39.
    Ritchie JL, Harker LA: Platelet and fibrinogen survival in coronary atherosclerosis: Response to medical and surgical therapy. AM J CARDIOL 39: 595–598, 1977.PubMedCrossRefGoogle Scholar
  40. 40.
    Pflug EA: Unpublished observations.Google Scholar
  41. 41.
    Turpie AGG, Chernesky MA, Larke RPB, Moore S, Regoeczi E, Mustard JF: Thrombocytopenia and vasculitis induced in rabbits by newcastle disease virus. In THROMBOSIS AND HEMOSTASIS III CONGRESS ABSTRACTS. Durham, North Carolina, The Seeman Printery Inc., 1972, p. 344.Google Scholar
  42. 42.
    Packham MA, Greenberg JP, Scott S, Reimers HJ, Mustard JF: Modifications of rabbit platelets that shorten their survival. AM SOC OF HEMATOLOGY ABSTRACTS No. 523, 1977 (In Press).Google Scholar
  43. 43.
    Greenberg J, Packham MA, Cazenave J-P, Reimers HJ, Mustard JF: Effects on platelet function of removal of platelet sialic acid by neuraminidase. LAB INVEST 32: 476–484, 1975.PubMedGoogle Scholar
  44. 44.
    Cazenave J-P, Reimers JH, Kinlough-Rathbone RL, Packham MA, Mustard JF: Effects of sodium periodate on platelet functions. LAB INVEST 34: 471–481, 1976.PubMedGoogle Scholar
  45. 45.
    George JN, Lewis PC: Membrane glycoprotein loss from circulating platelets: Inhibition by dipyridamole and aspirin. THROMB HAEMOSTAS 38: 111, 1977.Google Scholar
  46. 46.
    Reimers JH, Kinlough-Rathbone RL, Cazenave J-P, Senyi AF, Hirsh J, Packham MA, Mustard JF: In vitro and in vivo function of thrombin-treated platelets. THROMB HAEMOSTAS 35: 151–166, 1976.Google Scholar
  47. 47.
    Harker LA, Hanson SR, Hoffman AS: Platelet kinetic evaluation of prosthetic material in vivo. ANN NY ACAD SCI 283: 317–331, 1977.CrossRefGoogle Scholar
  48. 48.
    Harker LA, Slichter SJ: Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N ENGL J MED 283: 1302–1305, 1970.PubMedCrossRefGoogle Scholar
  49. 49.
    Harker LA, Slichter SJ, Sauvage LR: Platelet consumption by arterial prostheses: The effects of endothelialization and pharmacologic inhibition of platelet function. ANN SURG 186: 594–601, 1977.PubMedCrossRefGoogle Scholar
  50. 50.
    Harker LA: The kinetics of platelet production and destruction in man. In CLINICS IN HEMATOLOGY, Vol. 6, No. 3, edited by Lewis SM. London, England, WB Saunders, Inc., 1977, pp. 671–693.Google Scholar
  51. 51.
    Steele PP, Weily HS, Davies H, Genton E: Platelet function studies in coronary artery disease. CIRCULATION 48: 1194–1200, 1973.PubMedCrossRefGoogle Scholar
  52. 52.
    Sullivan JM, Harken DE, Gorlin R: Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N ENGL J MED 284: 1391–1394, 1971.PubMedCrossRefGoogle Scholar
  53. 53.
    Ross R, Glomset J, Kariya B, Harker LA: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. PROC NATL ACAD SCI USA 71: 1207–1210, 1974.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • Laurence A. Harker
    • 1
  • Russell Ross
    • 1
  1. 1.Harborview Medical Center and the School of MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations